🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. rhASA - Dose Level 1

    Takeda

    Metachromatic Leukodystrophy (MLD)

    phase 1 mab completed

    1 trial

  2. rhPTH(1-84)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. sulfamethoxazole + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  4. teduglutide

    Takeda

    Pharmacokinetics and Safety of Elevated Doses

    phase 1 small molecule completed

    1 trial

  5. "Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

    Takeda

    Cramps

    approved small molecule completed

    1 trial

  6. 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  7. 1-84 parathyroid hormone

    Takeda

    Shoulder Fractures

    approved small molecule active

    1 trial

  8. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  9. ADVATE

    Takeda

    Hemophilia A

    approved mab completed

    1 trial

  10. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  11. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial

  12. ARALAST NP

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved mab terminated

    1 trial

  13. Adalimumab

    Takeda

    Crohn's Disease

    approved small molecule active

    1 trial

  14. Alofisel 5 × 106 cells/mL dispersion for injection.

    Takeda

    Perianal fistulising Crohn´s disease

    approved small molecule active

    1 trial

  15. Alogliptin

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    6 trials

  16. Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    approved mab completed

    1 trial

  17. Alpha1-proteinase inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved mab completed

    1 trial

  18. Ampicillin

    Takeda

    Surgical Site Infection

    approved small molecule completed

    1 trial

  19. Anagrelide

    Takeda

    Thrombocythemia, Hemorrhagic

    approved small molecule completed

    1 trial

  20. Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method

    Takeda

    Hemophilia A

    approved mab completed

    4 trials

  21. Antihemophilic factor, recombinant, manufactured protein-free

    Takeda

    Hemophilia A

    approved small molecule completed

    6 trials

  22. Azilsartan

    Takeda

    Essential Hypertension Complicated by Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  23. Azilsartan

    Takeda

    Essential Hypertension With Stable Angina and Dyslipidemia

    approved small molecule terminated

    1 trial

  24. Azilsartan Medoxomil

    Takeda

    Essential Hypertension

    approved small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources